Tang Capital Management’s NextCure NXTC Stock Holding History

Tang Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,679	Closed	-$194K	–	211
2025 Q1	$194K	Sell	33,679 -24,654	-42%	-$217K	0.01%	196
2024 Q4	$540K	Buy	58,333 +3,967	+7%	+$58.4K	0.04%	171
2024 Q3	$894K	Buy	54,366 +4,116	+8%	+$75.7K	0.06%	116
2024 Q2	$959K	Buy	50,250 +38,207	+317%	+$743K	0.1%	94
2024 Q1	$322K	Sell	12,043 -26,951	-69%	-$464K	0.03%	96
2023 Q4	$533K	Buy	38,994 +5,661	+17%	+$82K	0.05%	114
2023 Q3	$516K	Hold	33,333	–	–	0.07%	95
2023 Q2	$720K	Hold	33,333	–	–	0.11%	84
2023 Q1	$592K	Buy	+33,333	New	+$642K	0.09%	85
2021 Q4	–	Sell	-25,000	Closed	-$2.02M	–	31
2021 Q3	$2.02M	Hold	25,000	–	–	0.42%	19
2021 Q2	$2.41M	Buy	+25,000	New	+$2.56M	0.48%	16

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPA

Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return

Tang Capital Management's NXTC Position: Q2 2025 in Review

Tang Capital Management sold out of NextCure (NXTC) in Q2 2025, closing a stake of 33,679 shares — an estimated $194K sold.

Tang Capital Management first reported a position in NXTC in Q2 2021 and held it in 11 quarters. The position peaked at $2.41M in Q2 2021. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2025.

Tang Capital Management reported no remaining NextCure position as of Q2 2025 after selling out during the quarter.
Tang Capital Management sold 33,679 NextCure shares in Q2 2025, an estimated $194K.
Tang Capital Management first reported a position in NextCure in Q2 2021 and held it in 11 quarters.
Tang Capital Management's NextCure position peaked at $2.41M in Q2 2021.
30 funds tracked by Wall St. Rank held NextCure as of Q2 2025.

Based on Tang Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.